Shaik Nayeem Uddin: Clopidogrel and Omeprazole Combination Can Quietly Reduce A Life-Saving Effect
Shaik Nayeem Uddin, Global Outreach – Student of the Member American Society for Microbiology, shared a post on LinkedIn:
“A commonly prescribed combination can quietly reduce a life-saving effect.
Let that sink in.
Clopidogrel is a prodrug.
It needs CYP2C19 to become active.
Now introduce Omeprazole.
CYP2C19 gets inhibited, which leads to reduced activation and consequently decreased protection.
What this really means is:
A patient you’re trying to protect from thrombosis may not be getting the full benefit of therapy.
This matters more in:
- Post-MI patients
- Stent placements
- High cardiovascular risk cases
The fix isn’t complicated.
Prefer Pantoprazole when needed
Simple change. Real impact.
Here’s the bigger point:
Drug interactions aren’t rare. They’re routine and often overlooked.
And this is exactly where clinical thinking matters.
This is Part 1 of my series:
Drug Interactions Every Clinician Should Know
If you’re in healthcare, this is something you’ll see more often than you think.
Have you encountered this in clinical practice?”

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments
-
Nov 16, 2026, 12:44Stefan Prendić: How Intronic Variants Affect Rh Blood Group Antigen Expression
-
Nov 16, 2026, 12:26Samwel Mikaye: Understanding Warfarin and Its Clinical Management
-
Nov 16, 2026, 12:14Sophia Delicou: Ensuring Lifelong Health Beyond Stem Cell Transplantation
-
Nov 16, 2026, 12:06Edward Lee Carter: Has PEPPER Changed the Role of Aspirin in Arthroplasty VTE Prophylaxis?
-
Nov 16, 2026, 11:53Eduardo Ortiz Bello: The Endothelium in Hemostasis and Microcirculation
-
Nov 16, 2026, 11:51Phil Spinella: Advancing Transfusion Medicine Through Collaboration
-
Nov 16, 2026, 11:46Madiha Chowdhury: Behind the Scenes of Blood Transfusion Services
-
Nov 16, 2026, 11:43Nasir Al Allawi: Honouring Excellence in Haematopathology